Skip to main content
. 2019 Aug 27;160(11):2646–2662. doi: 10.1210/en.2019-00493

Table 1.

Effect of Maternal LPS and (+)-Naloxone Treatment on Body Morphometry (Absolute Weight) in Male and Female Progeny at 20 wk

Absolute Weight PBS (+)-Naloxone LPS LPS/(+)-Naloxone
Male progeny
 N, pups (dams) 24 (10) 21 (7) 14 (5) 25 (7)
 Total body weight, g* 25.0 ± 0.5a 27.5 ± 0.6b 26.6 ± 0.8a,b 25.9 ± 0.6a
 Lean body weight, g 24.4 ± 0.4a 27.1 ± 0.4b 24.9 ± 0.5a 25.6 ± 0.4a,b
 Total muscle, mg§ 748 ± 19a,b 831 ± 20c 692 ± 25b 817 ± 20a,c
 Total central fat, mg^ 734 ± 34a 902 ± 36b 864 ± 46a,b 840 ± 37a,b
 Muscle/central fat ratio 1.05 ± 0.04a 0.95 ± 0.04a,b 0.84 ± 0.06b 1.00 ± 0.05a,b
 Quadriceps, mg# 325 ± 9a 365 ± 10b 277 ± 12c 358 ± 10a,b
 Triceps, mg# 195 ± 6a,b 218 ± 7a 188 ± 8b 216 ± 7a,b
 Biceps, mg# 31.7 ± 2.7 29.5 ± 2.9 34.2 ± 3.7 29.3 ± 3.0
 Gastrocnemius muscle, mg 197 ± 7 218 ± 8 193 ± 10 215 ± 8.0
 Retroperitoneal fat, mg 405 ± 21a 498 ± 23b 420 ± 29a,b 434 ± 23a,b
 Perirenal fat, mg 53.4 ± 4.7a 69.8 ± 6.4a,b 70.5 ± 5.1a,b 72.7 ± 5.2b
 Epididymal fat, mg 276 ± 18a 334 ± 19a,b 374 ± 24b 333 ± 19a,b
Female progeny
 N, pups (dams) 21 (10) 8 (5) 9 (4) 13 (7)
 Total body weight, g* 21.9 ± 0.5 22.8 ± 0.7 21.4 ± 0.8 21.7 ± 0.6
 Lean body weight, g 21.0 ± 3.8 22.0 ± 6.2 20.3 ± 5.8 20.7 ± 0.5
 Total muscle, mg§ 587 ± 15a,b 661 ± 24a 541 ± 23b 608 ± 20a,b
 Total central fat, mg^ 716 ± 34 618 ± 55 650 ± 52 628 ± 45
 Muscle/central fat ratio 0.87 ± 0.05 1.13 ± 0.09 0.88 ± 0.08 0.99 ± 0.07
 Quadriceps, mg# 252 ± 8a,b 293 ± 13a 231 ± 12b 261 ± 11a,b
 Triceps, mg# 149 ± 5a 164 ± 7a 122 ± 7b 156 ± 6a
 Biceps, mg# 25.6 ± 1.6 25.9 ± 2.7 29.8 ± 2.5 25.5 ± 2.2
 Gastrocnemius muscle, mg 162 ± 7 179 ± 11.4 158 ± 11 166 ± 9
 Retroperitoneal fat, mg 388 ± 14 396 ± 23.1 359 ± 22 375 ± 19
 Perirenal fat, mg 39.2 ± 2.9 42.4 ± 4.4 32.5 ± 4.7 39.8 ± 3.9
 Parametrial fat, mg 288 ± 26 190 ± 42 249 ± 39 213 ± 34

Different superscript letters (a, b, and c) indicate differences between treatment groups (P < 0.05). The number of progeny in each group is indicated, with the number of pregnant dams in parentheses. Other organs are shown in an online repository (46).

*

Data are estimated marginal mean ± SEM absolute weights in 20-wk-old male and female progeny of dams administered LPS and/or (+)-naloxone in late gestation. Effect of treatment group was analyzed by mixed model linear repeated measures ANOVA, using dam as subject and litter size as covariate.

§

Total muscle is the sum of all muscles measured.

^

Total central fat is the sum of all fat depots measured.

#

Combined weight of left and right organs.